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Metabolism and Excretion of 2-Ethoxyethanol
in the Adult Male Rat
by Kenneth L. Cheever,* Harry B. Plotnick,*
Donald E. Richards* and Walter W. Weigel*
The routes of 14C excretion following the administration of a single oral 230 mg/kg body weight dose of
2-ethoxyethanol [ethanol-1,2-'4C] or 2-ethoxyethanol [ethoxy-1-'4C] to male Sprague-Dawley rats were
investigated. Elimination ofthe '4C by the urinary route accounted for 76 to 80% ofthe dose within 96 hr.
The main pathway of biotransformation is oxidation to the corresponding acid, with some subsequent
conjugation of the acid metabolite with glycine. The major metabolites, ethoxyacetic acid and N-ethoxy-
acetyl glycine, representing 73 to 76% of the administered dose, were eliminated in the urine. The major
difference in the metabolic profiles ofthe two radiochemicals was in the rate and amount of "4CO2 expired
via the lung. Of the administered 14C, 11.7% of the ethoxy-labeled and 4.6% of the ethanol-labeled
compounds were eliminated as CO2. The biological half-time was 9.9 ± 1.5 hr for the ethoxy-labeled
compound and 12.5 ± 1.9 hr for the ethanol label. After administration ofthe ethanol-labeled compound,
the only radiolabeled component found in the rat testes was identified as ethoxyacetic acid. Results ofthis




based glycol ether produced in the United States (1).
The chemical has been of commercial importance for
more than 50 years, being used primarily as a solvent
and as anintermediate intheproduction of2-ethoxyethyl
acetate.
No chronic health effects resulting from industrial
use of 2-ethoxyethanol have been reported. However,
effects of 2-ethoxyethanol in animals include tubular
degeneration in the kidney (2), erythrocyte hemolysis
(3,4), and reduced leukocyte count (5). More recently,
Nelson et al. (6) showed neurochemical and behavioral
changes in the offspring of female rats exposed to
2-ethoxyethanol.
Although no adverse reproductive effects resulting
from human exposure to 2-ethoxyethanol have been
reported, testicular damage in rats exposed to the
chemical was described as early as 1942. In that year,
Morris et al. (7) showed that rats developed tubular
atrophy and edema of the testes after the oral admini-
stration of 2-ethoxyethanol. Similar effects have also
been noted in mice (5,8). Miller and his co-workers have
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demonstrated that 2-methoxyethanol, a closely related
glycolether, causesdegeneration ofthegerminalepithe-
lium ofthe testes ofrats (9). Subsequently, Miller et al.
(10) showed that a similar condition resulted from the
administration of methoxyacetic acid, a metabolite of
2-methoxyethanol (11). The metabolism of two other
ethylene glycol monoalkyl ethers, n-butoxyethanol
(12,13) and isopropoxyethanol (14), has been reported
to proceed by oxidation to the corresponding carboxylic
acid. Conjugation of isopropoxyethanol (14) and 2-
ethoxyethanol (15) metabolites with glycine has been
reported. In a previous study of the biotransformation
of 2-ethoxyethanol in the rat, Jonsson et al. (15)
identified ethoxyacetic acid and N-ethoxyacetyl glycine
as urinary metabolites. These investigators, however,
recoveredonlyanestimated30%oftheadministereddose.
The objectives of this study were to supplement the
earlier work on the biotransformation of 2-ethoxy-
ethanol in the rat by determining the fate of the
compound following oral administration and to identify
the chemical species associated with testicular damage.
Methods
Chemicals and Dosing Solutions
The test compound, 2-ethoxyethanol (99%), was pur-
chased from Aldrich Chemical Company, Milwaukee,CHEEVER ET AL.
WI. Both 2-ethoxyethanol [ethanol-1,2-14C] and 2-
ethoxyethanol [ethoxy-1-14C] with specific activities of
3.47 mCi/mmole and 2.69 mCi/mmole, respectively,
were purchased from New England Nuclear, Boston,
MA. Subsequent purification and analysis of these
radiochemicals by high-performance liquid chroma-
tography (HPLC) resulted in a radiochemical purity of
99.6% for each compound. The reference compound,
ethoxyacetic acid (98%), was purchased from Aldrich
Chemical Company. Ethoxyacetyl chloride (b.p. 124°C,
uncorr.) was synthesized in accordance with the general
method of Freed (16). N-Ethoxyacetyl glycine ethyl
ester (b.p. 107.5°C/0.01 mm, uncorr.) was synthesized
by reaction of ethoxyacetyl chloride with glycine ethyl
ester using the method of Wolf and Niemann (17).
Treatment solutions were prepared by dissolving
2-ethoxyethanol [ethanol-1,2-14C] or 2-ethoxyethanol
[ethoxy-1-14C] along with ethoxyethanol in distilled
water to yield a concentration of 46 mg/mL with
specific activities of 0.123 ,uCi/mg and 0.117 ,uCi/mg,
respectively.
Animals, Doses and Collections
Male Sprague-Dawley [Crl:CD (SD)BR outbred],
cesarean-derived rats weighing 51 to 75 g, were ob-
tained from Charles River Breeding Laboratories, Inc.
(Wilmington, MA) and maintained on NIH-07 rat and
mouse diet (Ziegler Brothers, Inc., Gardners, PA) and
tap water ad libitum. After a 2-week quarantine
period, 70 rats, weighing 190 to 210 g, were used in a
preliminary study to determine the acute 14-day oral
LD50 of 2-ethoxyethanol.
The dose range forthe toxicity study was established
by treating groups of two rats with various amounts of
undiluted 2-ethoxyethanol. Upon initiation of the
toxicity experiment, the rats were starved overnight,
weighed (192.6 + 12.3), and randomly assigned to six
groups of ten rats each. Doses of 250, 500, 1000, 2000,
4000, and 8000 mg/kg body weight were administered,
by gavage, to all rats within the corresponding dosage
groups. These animals were observed for mortality
during the subsequent 14-day period. The LD50 value
was calculated from the mortality in the several groups
by the probit method of Finney (18).
In subsequent excretion and metabolism studies,
animals in the same weight range were transferred to
individual Roth-type glass metabolism cages. Labora-
tory air, dried and freed ofcarbon dioxide, organics, and
particulates, was passed through the metabolic cham-
bers at a flow rate of 0.5 L/min. Except for an 18-hr
starvation period immediately prior to dosing, the
animals had free access to food sticks formed by baking
ground NIH-07 diet with a raw egg binder. Distilled
waterwasavailablethroughouttheexperimentalperiod.
Following acclimatization to the cages for3 days prior to
dosing, animals were given a single oral 230 mg/kgbody
weight dose ofeither 2-ethoxyethanol [ethanol-1,2-14C]
or 2-ethoxyethanol [ethoxy-1-14C]. This dose corres-
ponds to 0.1 of the LD50 value determined in the
preliminary experiment. Air exiting each chamber was
passed first through a sorbent sampling tube consisting
of a 400-mg front section and a 200-mg back section of
activated charcoal (SKC Inc., Eighty Four, PA) for
collection of organic material appearing in the expired
air and then bubbled through a tower containing
ethanolamine to trap expired carbon dioxide. Sampling
tubes and ethanolamine solution in the towers were
changed periodically as required to avoid loss of
radioactivity. Urine was collected when voided for the
first 30 hr, and at 48, 72, and 96 hr after dosing. Urine
was diluted to 10 or25mL and stored at -20°C untiltime
of analysis. Feces were collected at 24-hr intervals and
also stored at -20°C. At the end ofthe 96-hr experimen-
tal period, the animals were killed by asphyxiation with
CO2. Residualradioactivityinthemetabolismcages was
collected by washing first with water and then with
methanol.
In a separate experiment, six animals, weighing 190
to 210 g, were starved for an 18-hr period and given
a single oral 230 mg/kg body weight dose of 2-
ethoxyethanol [ethanol-1,2-14C]. Animals were killed
by decapitation and exsanguination at 1 hr intervals
after dosing. Testes were excised and stored at -20°C
until time of analysis.
Scintillation Spectrometry
Urine samples were prepared for 14C analysis by
dissolving duplicate 0.1-mL aliquots in 3 mL ofmetha-
nol and 10 mL of scintillator consisting of 5.5 g
Permablend I (Packard InstrumentCo., DownersGrove,
IL) per liter of toluene. Duplicate 1-mL aliquots of
ethanolamine solution were prepared forcountingin the
same scintillator. Feces samples were ground frozen
with microcrystalline cellulose (E. Merck, Darmstadt,
FR.G.) using a Model A10 analytical mill (Tekmar
Company, Cincinnati, OH). Five portions ofeach milled
feces sample were prepared for 1C analysis by combus-
tion in a Tri-Carb Model B306 sample oxidizer (Packard
Instrument Co.). Front and back sections of charcoal
from sample collection tubes were combusted sepa-
rately inthe sample oxidizer. Carcasses were solubilized
in 1 N NaOH prepared in 70% (v/v) aqueous methanol,
and five portions of the digest were combusted. Cage
washings were homogenized using a Polytron Model
PCU-1 homogenizer equipped with aPC-10 probe (Kine-
matica Gmbh, Luzern, Switzerland), and five 0.5-mL
aliquots were combusted. Carbon-14 was determined
using a Model LS8100 liquid scintillation spectrometer
(Beckman Instruments, Inc., Fullerton, CA), and data
werecorrected forbackground and quenching. Counting
efficiency was calculated using an external standard.
Separation and Isolation of Metabolites
Urinary metabolites were separated by HPLC with a
50 cm x 9 mm internal diameter stainless steel column
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packed with Partisil-10 OD-2 (Whatman, Inc., Clifton,
NJ). A model ALC/GPC 201 high-performance liquid
chromatograph equipped with two Model 6000A pumps
and a Model U6K injector (Waters Associates, Inc.,
Milford, MA) was used throughout the study. Solvent
gradient conditions were controlled by a Model 720
system controller (Waters Associates, Inc.). Individual
urine samples were thawed, adjusted to pH 3 with
glacial acetic acid, and filtered through a 0.45-,um
pore size disposable filter assembly (Acrodisk, Gelman
Sciences, Ann Arbor, MI) prior to HPLC analysis. A
portion ofeach ofthese samples was initially chromato-
graphed for 20 min isocratically with 1% acetic acid
in water. Metabolites were then eluted by using a
methanol:1% acetic acid solvent system, linearly pro-
grammed from 15% to 80% methanol in 40 min. The
solvent flow rate was maintained at 1 mL/min during
the 60-min period of analysis. Radioactive metabolites
were detected and quantified by using an in-line Tri-
Carb RAM 7500 radioactivity monitor equipped with a
quartz flow cell packed with a solid scintillator (Packard
Instrument Co.).
Another portion ofurine was acidified to pH 1 with 6
N HCl and heated at 90°C for 4 hr under nitrogen to
hydrolyze possible conjugates. The urine was then
adjusted to pH 3 with 6 N NaOH, filtered, and analyzed
by HPLC.
Urinary metabolites were collected, pooled by reten-
tion time, and lyophilized using a Model 75035 freeze
dryer (Labconco Corporation, Kansas City, MO). Resi-
dues were subsequently taken up in 1 mL of methanol
for identification of metabolites by chromatographic
techniques.
Testes were alsoexamined forthe presenceofradioac-
tive compounds by HPLC. Rat testes were thawed,
minced, and homogenized in three volumes of distilled
water using a Polytron Model PCU-1 homogenizer
equipped with a PC-10 probe. Homogenates were
lyophilized, and the residues were extracted three times
with 1-mL volumes of methanol. These extracts were
combined and concentrated to 1 mL for HPLC analysis
using the same chromatographic conditions described
previously. The single radioactive fraction was collected
for further characterization by gas-liquid chromatogra-
phy (GLC) and thin-layer chromatography (TLC).
Characterization of Metabolites
Retention times of metabolites isolated from the
urine and testes and of reference compounds were
determined on two different gas chromatographic
columns. Initially the metabolites were individually
chromatographed on a 183 cm x 2 mm glass column
packed with 10% SP-2100 on 100/120 mesh Supelcoport
(Supelco, Inc., Bellefonte, PA) installed in a Model
3920B gas chromatograph (Perkin-Elmer Corp.,
Norwalk, CT). The oven temperature was programmed
from 50 to 250°C at 2°C/min, with a nitrogen carrier
gas flow rate of 30 cm3/min. Metabolites found to be
nonvolatile were esterified by using the general method
of Thenot et al. (19) and rechromatographed. Metabo-
lites were also chromatographed on a 183 cm x 2 mm
glass column packed with 10% SP-1200/1% H3PO4 on
80/100 mesh Chromosorb W AW (Supelco, Inc.), a
column useful for the separation of organic acids. The
oven temperature was programmed from 70 to 200NC at
2°C/min. A nitrogen carrier gas flow rate of30 cm3/min
was used.
Metabolites were further characterized by TLC Rt
values. Radioactive metabolites were co-chromato-
graphed with reference compounds on silica-gel
precoated glass plates (E. Merck, 60 F 254, 0.25 mm
layer thickness). Chromatograms were developed with
ethyl acetate:acetic acid:water (90:5:5, v/v). Areas cor-
responding to radioactive metabolites were located by
using a Model 7230 radiochromatograph x-y scanner
(Packard Instrument Co.) with a collimator opening of
1.5 mm2 and a helium:isobutane (99.05:0.95, v/v) count-
ing gas flow rate of 5 cm3/min. Reference compounds
were located by observingthe quenching offluorescence
activated by 254 nm radiation and by color reactions
with either iodine vapor or 0.05% Bromocresol Green
reagent (E. Merck).
The two major urinary metabolites or their ethyl
esters were further characterized by determination of
boiling points at atmospheric or reduced pressure. In
addition, mass spectra of the major urinary metabolite
and the corresponding reference compound were ob-
tained by using a Model 5982A mass spectrometer
(Hewlett-Packard Co., PaloAlto, CA) operatingwith an
electron energy of 70 eV A model 5711 gas chroma-
tograph (Hewlett-Packard Co., Avondale, PA), fitted
with a 91 cm x 2 mm glass column packed with 3%
SP-2300 on 100/120-mesh Supelcoport (Supelco, Inc.),
was interfaced to the mass spectrometer through a
glass-jet separator. The oven temperature was pro-
grammed from 100 to 150°C at 2°C/min. A helium
carrier gas flow rate of 30 cm3/min was used. All mass
spectral data were acquired and processed using a
Model 5834A data system (Hewlett-Packard Co.).
Statistical Analysis
Statistical differences between groups were deter-
mined using Student's t-test. The biological half-times
of the two radioisotopes were calculated by linear
regression analysis.
Results
Determination of Acute Toxicity
The single-dose oral LD50 for 2-ethoxyethanol deter-
mined in 190 to 210 g male Sprague-Dawley rats, based
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FIGURE 1. Cumulative 30-hr '4CO2 excretion after oral administration of 230 mg/kg doses of radiolabeled 2-ethoxyethanol to the adult male
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FIGURE 2. Cumulative 96-hrurinary 14C excretion afteroraladmini-
stration of230 mg/kg doses ofradiolabeled 2-ethoxyethanol to the
adult male rat (mean ± SE).
Excretion of Radioactivity
The principal route of excretion of the administered
radioactivity was via the kidneys. Rats treated with the
ethanol-labeled material excreted 80.6% of the dose in
the 96-hr collection period. The corresponding value for
rats treated with the ethoxy-labeled compound was
75.5% ofthe dose. When the amounts of 14C in the cage
washes-considered to be residual urine -were added,
Table 1. lbtal 96-hr recovery of 14C.
% of administered 2-ethoxyethanol
Sample [Ethanol-1,2-l4CIa [Ethoxy-l1-4C]b
Urine 80.6 ± 2.2 75.6 ± 2.1
CO2 4.6 ± 0.5c 11.7 ± 1.0c*
Volatile organics 0.2 ± 0.Oc 0.4 ± 0.Oc
Feces 4.5 ± 1.2 2.7 ± 0.7
Carcass 4.6 ± 0.2* 1.8 ± 0.2
Cage Wash 4.8 ± 1.9 2.2 ± 0.8
Tbtal recovery 99.3 ± 6.0 94.4 ± 4.8
aAnimals received 230 mg/kg doses of 2-ethoxyethanol [ethanol-
1,2-14C] (specific activity = 0.123 p.Ci/mg; mean + SE, n = 4)
bAnimals received 230 mg/kg doses of 2-ethoxyethanol [ethoxy-
1-14C] (specific activity = 0.117 uCi/mg; mean + SE, n = 5). C30-hr value.
*Statistically different from corresponding value by Student's t
test, p < 0.01.
the total urinary recoveries became 85.4% and 77.8% of
the dose for the ethanol-labeled and ethoxy-labeled
compounds, respectively. The elimination of radioactiv-
ity in the urine was rapid with 71.6% of the ethanol-
label and 69.9% of the ethoxy-label excreted over the
first 24 hr. Only an additional 6 to 9% of the adminis-
tered radioactivity was excreted in the urine duringthe
ensuing 72 hours (Fig. 1). Administration ofthe ethoxy-
labeled compound resulted in the excretion of 11.7% of
the dose as respiratory 14CO2. In contrast, the ethanol-
labeled compound gave rise to only 4.6% ofthe dose as
14CO2. After the first 10 hr, the output of labeled CO2
rapidly declined. By 30 hr, the expiration of 14CO2 had
virtually ceased (Fig. 2), and sampling was discon-
tinued at that time. Only trace amounts of volatile
organics were found in the breath of rats treated
with either radiolabeled compound. Relatively minor
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in the carcass at 96 hr after treatment with either
radiochemical. The biological half-times forthe ethanol-
and ethoxy-labeled compounds were 12.5 + 1.9 hr and
9.9 + 1.5 hr, respectively. Total recovery of 14C was
99.3% from rats dosed with 2-ethoxyethanol [ethanol-
1,2-14C] and 94.4% from those dosed with 2-ethoxy-
ethanol [ethoxy-1-14C]. These results are summarized
in Table 1.
Metabolism of 2-Ethoxyethanol
The urinary metabolites excreted by rats following
administration of either radiochemical were separated
by HPLC and quantified by scintillation spectrometry.
The relative amounts ofeach metabolite were calculated
by summation ofthese analytical results for each urine
sample collected over the 96-hr period (Table 2). Ofthe
12 distinct radiolabeled components present inthe urine
of rats treated with either radiochemical, only two
minor components were found not to be common
metabolites of both. Urinary metabolite E, represent-
ing 1.4% of the administered 14C, was specific for the
ethanol-labeled compound, whereasmetabolite F, repre-
senting 1.5%, appeared only in the urine ofrats treated
with the ethoxy-labeled compound.
The two major metabolites together accounted for 73
Table 2. 96-Hr urinary metabolic profile.
Metabolite HPLC retention time(Rt), min [Ethanol-1,2-l4C]a [Ethoxy--14C]b
A 25.8 < 0.01 < 0.01
B 27.4 0.21 ± 0.02 0.01 t 0.05
C 28.8 1.76 ± 0.53 0.09 ± 0.01
D 42.6 0.32 ± 0.09 0.18 ± 0.03
E 45.6 1.44 ± 0.41
F 47.4 1.51 t 0.23
G 50.2 32.13 t 2.23 28.04 ± 1.32
H 52.5 43.44 ± 2.09 44.88 ± 2.62
I 53.4 0.25 ± 0.05 0.16 ± 0.05
J 54.0 0.42 ± 0.09 0.27 ± 0.13
K 56.0 0.18 ± 0.03 0.07 t 0.03
L 58.4 0.10 ± 0.02 0.02 ± 0.01
Total recovery 80.25 ± 5.56 75.32 ± 4.48
aAnimals received 230 mg/kg doses of2-ethoxyethanol-1,214C] (specific activity = 0.123 ,uCi/mg; mean ± SE, n = 4).
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Table 3. Comparison of urinary metabolites of 2-ethoxyethanol with reference compounds.
Compound Retention time A, mina Retention time B, minb Rfc Boiling point, °C
Ethoxyacetic acid 4.9 23.2 0.33 206
Metabolite H 4.7 23.3 0.32 207
Testicular metabolite 4.5 23.3 0.32
N-Ethoxyacetyl glycine, ethyl ester 22.6 47.1 0.25 107.5/0.01 mm
Metabolite G, ethyl ester 23.0 45.3 0.25 107.5/0.01 mm
2-Ethoxyethanol 5.3 2.5 0.54 135.1
'GLC retention time (min) using a 183 cm x 2 mm i.d. glass column packed with 10% SP-2100 on 100/120-mesh Supelcoport. Oven temp-
erature programmed from 50° to 2500 at 2°C/min with 30 cm3/min nitrogen carrier gas.
bGLC retention time using a 183 cm x 2 mm i.d. glass column packed with 10% SP-1200/1% H3PO4 on80/100-mesh Supelcoport. Oven temp-
erature programmed from 70° to 200°C at 2°C/min with 30 cm3/min nitrogen carrier gas.
CTLC Rfvalue of compounds spotted on E. Merck Silica gel F 60 precoated plates and run 10 cm with ethyl acetate:acetic acid:water (95:5:5)
mobile phase.
to 76% of the administered radioactive dose. The more
abundant ofthese, metabolite H, accounted for43.4% of
the administered ethanol-labeled compound and 44.9%
of the ethoxy-labeled compound. The second most
abundant, metabolite G, amounted to 32.1% of the
administered ethanol-labeled compound and 28.0% for
the ethoxy-labeled compound. The remaining eight
radioactive components accounted for less than 3% of
the administered dose. Analysis by HPLC of urine
subjected to acid hydrolysis showed a disappearance of
metabolite G with a concomitant increase in metabolite
H, indicating the presence of a possible glycine
conjugate.
Urinary metabolite H, isolated by HPLC, was fur-
ther purified by fractional distillation at atmospheric
pressure to yield a colorless liquid, boiling at 207°C.
This metabolite was subsequently identified as
ethoxyacetic acid by comparison ofboiling points, GLC
retention times on two different columns, and TLC Rf
values with those ofthe authentic reference compound.
The identification of this compound was confirmed by
mass spectral analysis (Fig. 3).
Urinary metabolite G did not elute from the gas
chromatographic column under the conditions used.
Subsequently, the ethyl ester of this metabolite was
formed and isolated by fractional distillation at reduced
pressure toyield acolorlessliquidboilingat 107.5°C/0.01
mm Hg. This metabolite was further identified as
N-ethoxyacetyl glycine by comparison ofboiling points,
GLC retention times on two different columns, and TLC
Rf values of its ethyl ester with those of the authentic
compound (Table 3).
Minor metabolites in the urine, accounting for only 3
to 5% of the administered 14C, were not identified.
However, their failure to respond to conditions of
hydrolysis or esterifiction indicates that these metabo-
lites were not amino acid or glucuronic acid conjugates.
Identification of Metabolites Isolated
from Testes
Analysis of extracts of rat testes by HPLC indicated
that the amount of14C in the testes peaked at 2 hr after
administration of the ethanol-labeled compound and
Table 4. Testicular 14C levels after administration
of 2-ethoxyethanol [ethanol-1,2-"4C].







'Animals received 230 mg/kg oral doses of 2-ethoxyethanol
[ethanol-1,2-'4C] (specific activity = 0.117 ,uCi/mg). Testes of each
animal were homogenized in three volumes of distilled water, and
lyophilized. Residues were extracted three times with 1-mL portions
of methanol and chromatographed by HPLC.
declined rapidly over the ensuing 4-hr period (Table 4).
The single radioactive HPLC peak was subsequently
identified as ethoxyacetic acid by comparison of GLC
retention times on two different columns, TLC Rt
values and HPLC retention times with those of the
authentic compound.
Discussion
The results ofthis study indicate that metabolism of
2-ethoxyethanol in the rat proceeds primarily through
oxidation to the corresponding acid, with some subse-
quent conjugation of the acid metabolite with glycine.
These results confirm the work ofJonsson et al. (15) and
are consistent with the biotransformation pathways
reported for other ethylene glycol monoalkyl ethers
(11-14). In the present study, the principal difference
observed in the metabolic profiles of the two different
labeled 2-ethoxyethanols was in the higher amount of
expired 14CO2 from the ethoxy-labeled compound with a
concomitant shortening of the biological half-time. Af-
ter administration of radiolabeled 2-ethoxyethanol, a
single metabolite, ethoxyacetic acid, was identified in
the rat testes.
Although the metabolism of 2-ethoxyethanol has
been studied to some extent, information pertaining to
its quantitative metabolism and excretion has not been
previouslyreported. Afterincubationof2-ethoxyethanol
withAcetobactersuboxidans, Hrotmatkaand Polesofsky
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Table 5. Metabolism of 2-ethoxyethanol.
Metabolite reported Species Reference




N-Ethoxyacetyl glycine Rat (15)
(20) reported finding ethoxyacetic acid and suggested
that this metabolite would be more toxic than the
parent compound. Using a similar bacterial system,
Harada and Nagashima (21) noted that 2-ethoxyethanol
was utilized as the sole carbon source and postulated
that, following the initial conversion to ethoxyacetic
acid, the ether bond was cleaved. Jonsson et al. (15)
reported finding two metabolites, ethoxyacetic acid and
N-ethoxyacetyl glycine, in the urine of rats after oral
administration of2-ethoxyethanol. These investigators,
using unlabeled 2-ethoxyethanol, estimated that the
combined excretion ofthe two metabolites amounted to
approximately 30% (mole/mole) of the given dose. The
results of the studies are summarized in Table 5.
The metabolism of 2-ethoxyethanol appears to be
complex as indicated by the number of radiolabeled
urinary components found by HPLC. The major
metabolites, ethoxyacetic acid and N-ethoxyacetyl
glycine, account for 73 to 76% of the administered
radioactivity. Many ofthe 10 minorurinary components,
representing 3-5% of the dose, may be products of
cleavage of the ether linkage. Unchanged 2-ethoxy-
ethanol was not detected in the urine. The 0.2 to 0.4% of
the administered 14C collected on charcoal was not
further characterized and may represent unchanged
2-ethoxyethanol expired via the lung.
Previous studies of ethylene glycol monoalkyl ethers
have noted 14CO2 in the expired breath of rats, but no
conclusions were drawn regarding possible cleavage of
the ether bond. Miller and his co-workers (11) found
that 12% of administered radioactivity was eliminated
as 14CO2 in 48 hr using 2-methoxyethanol [ethanol-
1,2-14C]. After administration of isopropoxyethanol
[ethanol-1 2-14C], Hutson and Pickering (14) recovered
16% as 1 CO2 in 96 hr. Since, in both studies, the
terminal carbon was radiolabeled, 14CO2 production
involving this portion ofthe molecule could not be ruled
out. Biological cleavage of the carbon-oxygen bond in
diethyl ether, however, has been reported in the rat (22),
rabbit (23), mouse (24) and man (25,26). In the present
study, cleavage of the ethoxy-labeled compound re-
sulted in the elimination of 11.7% ofthe dose as 14CO2.
However, only 4.6% ofthe administered ethanol-labeled
compound was eliminated as 14CO2. These results show
that the ether linkage of2-ethoxyethanol was cleaved to
the extent of at least 11.7% in the rat.
Although testicular damage has been reported in the
rat following administration of certain of the ethylene
glycol monoalkyl ethers (7,9), accumulation of the
compounds or their metabolites in the testes does not
appear likely. Miller et al. (10), studying radiolabeled
2-methoxyethanol, found only 0.13% ofthe orallyadmin-
istered 14C in the testes after 48 hr. In addition, these
investigators noted that the amount of 14C in the testes
was low in comparison with that in the blood, indicating
a lack ofaccumulation. In the present study, the level of
14C inthe testes was highest at2hrafterthe administra-
tion of2-ethoxyethanol [ethanol-1,2-14C] and decreased
rapidly thereafter. The only radioactive compound de-
tected in that tissue was ethoxyacetic acid. These
results are consistent with the findings of Miller et al.
(11) for methoxyacetic acid and suggest that the acid
metabolites may be the activating agents forthe testicu-
lar changes resulting from exposure to the ethylene
glycol monoalkyl ethers.
Mention of company or product names is not to be considered an
endorsement by the National Institute for Occupational Safety and
Health.
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